PREVENTING RELAPSE Lee B. Reichman, MD, MPH Northeast TB Controllers Meeting October 24, 2006 Princeton, New Jersey.

Slides:



Advertisements
Similar presentations
Renewing Health Canada’s strategy against TB for First Nations on-reserve Provincial Primary Care Tuberculosis Education Day October 28, 2011 Presented.
Advertisements

Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum.
TB and HIV: Tightly Linked… and Why We Should Care.
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Christine Lubinski Vice President for Global Health Infectious Diseases Society of America April 17, 2009 Germs Go Global Tuberculosis and HIV/TB Co-Infection.
OSHA Blood Borne Pathogen and Tuberculosis Training PART II Tuberculosis Author: Maxine Edwards, RN, ICP ECU Infection Control Presented by: Patti Goetz,
NCI Designation: Expanding Science and Promoting Health in the Region Name Title, Company Date.
1 Identifying Cases of MDR-TB Session 3. USAID TB CARE II PROJECT Old WHO recommendations RegimenIndications 4HREZ/2HR (Category I) New cases 2SHREZ/1HREZ/5HRE.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
How long is the duration of treatment for XDR-TB? At least 2 years (the same as MDR-TB). Doctors will monitor people with any form of confirmed drug resistant.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
SESSION 1: Introduction to DOT. DOT Curriculum Session 1 2 Worldwide TB Statistics 1.Approximately 8 million new cases of active TB each year 2.World.
Global and U.S. Tuberculosis Epidemiology and Principles of Control
The Changing Landscape of TB: Maryland TB in 2013 Presented by Dr. David Blythe Lisa Paulos, RN MPH, Epidemiologist Center for TB Control & Prevention.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Strategic Health Policy Directions in Refugee Resettlement Joy Baldwin Medical Services Branch Citizenship and Immigration Canada Vancouver B.C. February.
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
Health Care Reform Through the Cancer Lens State and Private Sector Reforms for Hispanic Healthcare Edward E. Partridge, MD National Board President American.
Operational Research in the 21 st Century. International Union Against Tuberculosis and Lung Disease (The Union) World’s oldest humanitarian organization.
Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.
Part 7 Health and Technology. Objectives Identify ways to take antibiotics correctly to prevent antibiotic resistance. 2. Discriminate between benefits.
Use of 12 weekly doses of isoniazid and rifapentine for the treatment of latent tuberculosis − Connecticut , Kelley Bemis, MPH CDC/CSTE Applied.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
Monitoring and Evaluation Module 12 – March 2010.
Tuberculosis Treatment Completion Among Persons Incarcerated at Diagnosis, U.S. TB Surveillance System, 1999–2008 Kiren Mitruka, MD, MPH (presented on.
WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps…
Epidemiology of tuberculosis. Peymane Adab, Richard Fielding, Susana Castan.
2007 National Healthcare Quality Report (NHQR) Health care quality continues to improve, but the rate of improvement has slowed Released March 3, 2008.
Max O’Donnell, Nesri Padayatchi, Iqubal Master, Garth Osburn, Robert Horsburgh Treatment of Extensively Drug Resistant Tuberculosis Among Patients with.
Why is Cultural Competency Important in the Practice of Medicine? Karen E. Schetzina, MD, MPH.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Progress of the Singapore TB Elimination Programme (STEP)
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
Division of Tuberculosis Elimination Centers for Disease Control and Prevention Tuberculosis in the United States National Tuberculosis Surveillance System.
Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2011 National Center for HIV/AIDS, Viral Hepatitis, STD, and.
Sanghyuk Shin, PhD Department of Epidemiology UCLA Fielding School of Public Health Aug 27, 2015 Tuberculosis and HIV Co-infection: “A Deadly Syndemic”
Epidemiology of TB and HIV/AIDS in the Caribbean Module 1 – March 2010.
+ AB 496 LGBT Cultural Competency for Health Care Providers Kirstee Novak GNRS 504 Bioethics April 8 th, 2015.
Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.
International Health Policy Program -Thailand Policy decision on multi drug resistant(MDR), extreme drug resistant(XDR) tuberculosis screening: How it.
Epidemiologic Studies Consortium Research CTCA meeting October 22, 2010 Lisa Pascopella, PhD, MPH California Department of Health Services.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Beyond Sputum Cups and Four Drugs The Responsibility of the Practicing Clinician in the Community Control of Tuberculosis V. R. Koppaka, MD, PhD Division.
Tuberculosis In Texas Presentation by: Brian R. Smith, M.D., M.P.H., Regional Director.
Epidemiology of Tuberculosis in African-American Population, United States Kenneth G. Castro, M.D. Assistant Surgeon General, USPHS Director,
Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Tuberculosis and the Ethics of Shared Responsibility Ross E.G. Upshur, BA(HONS), MA, MD, MSc, CCFP, FRCPC Canada Research Chair in Primary Care Research.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 7: GAP BETWEEN AVAILABILTY OF DRUG SUSCEPTIBILITY.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 8.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
The Future of Drug-Resistant TB: How Do We Prevent a Nightmare? (HINT: By Treating It!) David Dowdy, MD PhD B. Frank Polk Assistant Professor of Epidemiology.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Committee Task Statement (1)
Paul Stoffels, MD Vice Chairman, Chief Scientific Officer, Johnson & Johnson.
Presentation transcript:

PREVENTING RELAPSE Lee B. Reichman, MD, MPH Northeast TB Controllers Meeting October 24, 2006 Princeton, New Jersey

Reported TB Cases United States, 1982–2005 Year No. of Cases

Trends in Tuberculosis – United States, 2005 Deceleration of the decline in the overall national TB rate, the persistent disparities in TB rates between U.S.-born and foreign-born persons and between whites and racial/ethnic minorities, and the increase in MDR TB cases all threaten progress toward the goal of TB elimination in the United States Effective TB control and prevention in the United States require sufficient resources, continued collaborative measures with other countries to reduce TB globally, and interventions targeted to U.S. populations with the highest TB rates

The U-Shaped Curve of Concern

Tuberculosis: No Longer a Problem? CDC TB Related News Items Weekly Update 6 month sample: October 1, March 31, articles from 33 states on all aspects of TB 76 reports of TB outbreaks: (almost 1 every 2-3 days) –Schools and colleges38 –Prisons8 –Hospital/Nursing Home7 –Workplace16 –Homeless7 - J. Seggerson, NCET WIRE, April 2004

Federal News Radio

CNN

NBC 4

Results

TB Onboard

XDRTB 1539 Patients with Isolates sent 544 Culture-Positive for M.Tb –35% of total 221 Resistant to Isoniazid & Rifampin (MDR TB) –40% of M.Tb and 14% of total 53 Resistant to all tested drugs (XDR TB) –24% of MDR TB, 10% MTB and 3% of total -G. Friedland, Int Conf on AIDS, 2006

XDRTB Patients Prior TB Treatment or Hospitalization CharacteristicsXDR TB Patients n (%) Prior TB Treatment: No prior TB treatment26 (51%) Cure or completed treatment14 (28%) Default or Treatment Failure7 (14%) Prior Hospitalization:32 (64%) -G. Friedland, Int Conf on AIDS, 2006

XDRTB Mortality 52 of 53 (98%) of XDR patients have died Median survival from date sputum collected was 16 days (IQR days) –No significant difference by HIV status, previous or use of ARVs -G. Friedland, Int Conf on AIDS, 2006

The New York Times September 14, 2006 EDITORIAL: Extreme Tuberculosis More funding is needed to catch up with new, extensively drug-resistant strains of tuberculosis.

Patient Involvement in Medical Care Patients and their families have become increasingly involved— and influential—in all aspects of medical care In the mid-eighties, as the first anti-viral drugs for treating AIDS were being developed, activists demanded to participate in the design of clinical trials directed by the National Institutes of Health and pharmaceutical companies Inspired by the activists’ example, breast cancer patient- advocacy groups made similar requests The AIDS groups interrupted meetings and staged “die-ins” at the N.I.H. Eventually, the physicians in charge of planning the clinical trials agreed to their demands Laypeople now routinely sit on committees on the N.I.H. and on hospitals’ institutional review boards, which assess the ethicality and scientific merit of clinical trials

The Patient’s Charter for Tuberculosis Care

Initiated and developed by patients from around the world Outlines rights and responsibilities of people with tuberculosis Sets out the ways in which patients, the community, health providers (both private and public), and governments can work as partners in a positive and open relationship Practices principle of Greater Involvement of People with Tuberculosis Affirms that empowerment is catalyst for effective collaboration with health providers and authorities

Patient’s Rights You have the right to: Care; Dignity; Information; Choice; Confidence; Justice; Organization; Security

Patient’s Responsibilities You have the responsibility to: Share information; Follow treatment; Contribute to Community Health Show Solidarity

Deaths Due To: TB (annually)2 - 3,000,000 SARS813 Angola Marburg Hemorrhagic Fever 329 Avian Influenza144 Anthrax5 Mad Cow Disease1 (Cow) Smallpox0

Reichman’s Prediction The continued rise of the TB in the world and the leveling off of tuberculosis in the US portends a significant global resurgence of TB followed by a frightening resurgence of MDRTB still diagnosed and treated with old tools The resurgence will continue unabated followed by subsequent transmission to healthcare workers and through that vector to the community at large Subsequent global re-establishment of control of tuberculosis will then entail more staggering costs, both in cash and hysteria than has ever been contemplated New drugs and New Diagnostics and an effective vaccine will enhance the TB community’s success in turning this around which once again will depend on energizing others to make our case

INFORMATION LINE 18004TBDOCS ( )